Peak Pharmaceuticals, Inc. filed its 10-K on Dec 19, 2022 for the period ending Sep 30, 2021. In this report its auditor, Friedman LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.2 USD | +29.35% | -.--% | +200.58% |
1st Jan change | Capi. | |
---|---|---|
+200.58% | 98.81M | |
+10.29% | 3,082B | |
+8.12% | 84.92B | |
+5.55% | 78.23B | |
-13.73% | 54.06B | |
-24.43% | 46.79B | |
+19.98% | 45.87B | |
+21.26% | 42.65B | |
+60.27% | 37.28B | |
-9.36% | 24.89B |
- Stock Market
- Equities
- RMHI Stock
- News Retrieve Medical Holdings Inc
- Peak Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt